SPC125
Secúkínúmab
Status:
VeittApplication date:
6.7.2015Application published:
15.8.2015Grant published:
15.3.2017
Max expiry date:
18.7.2030Next due date:
31.8.2026Medicine name:
CosentyxMedicine for children:
Yes
Timeline
Today
6.7.2015Application
15.8.2015Publication
15.3.2017Registration
4.8.2026Expires
Marketing license
IS authorization number:
EU/1/14/980/001-005Date:
4.2.2015
Foreign authorization number:
EU/1/14/980Date:
15.1.2015
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, Basel CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1776142
Annual fees
Number
Paid
Expires
Payer
Number: 1
Paid: 8.8.2025
Expires: 4.8.2026
Payer: Árnason Faktor ehf.